Apelin Is a Prototype of Novel Drugs for the Treatment of Acute Myocardial Infarction and Adverse Myocardial Remodeling

In-hospital mortality in patients with ST-segment elevation myocardial infarction (STEMI) is 5–6%. Consequently, it is necessary to develop fundamentally novel drugs capable of reducing mortality in patients with acute myocardial infarction. Apelins could be the prototype for such drugs. Chronic adm...

Ausführliche Beschreibung

Bibliografische Detailangaben

Hauptverfasser:	Sergey V. Popov, Leonid N. Maslov, Alexandr V. Mukhomedzyanov, Boris K. Kurbatov, Alexandr S. Gorbunov, Michail Kilin, Viacheslav N. Azev, Maria S. Khlestkina, Galina Z. Sufianova
Format:	Artigo
Sprache:	Inglês
Veröffentlicht:	MDPI AG 2023-03-01
Schriftenreihe:	Pharmaceutics
Schlagworte:	heart ischemia/reperfusion apelin adverse remodeling
Online-Zugang:	https://www.mdpi.com/1999-4923/15/3/1029
Tags:	Tag hinzufügen Keine Tags, Fügen Sie das erste Tag hinzu!